Conclusion
Through the means of this literature review, we as the authors aspire to
provide an effective
go – to article; a summary, of the clinical findings of VEXAS.
An increasing interest in adult-onset inflammatory conditions, in the
recent years, have been noticed amongst rheumatologists. The innovative
genotype first approach utilised in the discovery of VEXAS could be a
motivation to incorporate similar study approaches to investigate other
rheumatological conditions.
The authors encourage further funding, research and study into VEXAS.
Further research into gene therapy is encouraged, which could
potentially help to correct and adjust the somatic mutations described
in this review article.